StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Protagenic Therapeutics, Inc.
NasdaqCM:PTIX
Sector
Location
Market Cap
USD 3.07 M
Share Price
USD 3.54
Avg Daily Volume
2,036,456
Change (1 day)
-3.01%
Change (1 year)
Change (YTD)
-3.54%
Protagenic Therapeutics, Inc. Revenue Per Share for the Trailing 12 Months (TTM) ending March 31, 2025: USD 0.00
Protagenic Therapeutics, Inc. Revenue Per Share is USD 0.00 for the Trailing 12 Months (TTM) ending March 31, 2025. Revenue per share indicates revenue generated per share; higher ratios suggest stronger performance and value.
-
Protagenic Therapeutics, Inc. Revenue Per Share for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 0.00.
-
Protagenic Therapeutics, Inc. Revenue Per Share for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 0.00.
-
Protagenic Therapeutics, Inc. Revenue Per Share for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 0.00.
-
Protagenic Therapeutics, Inc. Revenue Per Share for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 0.00.
Competitors
AbbVie Inc.
USD 189.99
ABBV
+4.37
2.35%
Novo Nordisk A/S
USD 69.18
NOVO-B.CO
-0.07
-0.11%
Roche Holding AG
USD 347.88
RO.SW
+1.27
0.37%
Novartis AG
USD 123.49
NOVN.SW
+2.27
1.88%
Abbott Laboratories
USD 136.26
ABT
+0.25
0.18%
AstraZeneca PLC
USD 142.95
AZN.L
+3.99
2.87%
Merck & Co., Inc.
USD 81.81
MRK
+2.65
3.35%
Amgen Inc.
USD 290.52
AMGN
+11.31
4.05%
Gilead Sciences, Inc.
USD 111.73
GILD
+0.86
0.78%
Pfizer Inc.
USD 25.04
PFE
+0.80
3.30%
Sanofi
USD 98.07
SAN.PA
+1.17
1.21%
Vertex Pharmaceuticals Incorporated
USD 452.16
VRTX
+6.96
1.56%
Bristol-Myers Squibb Company
USD 47.51
BMY
+1.22
2.64%
Chugai Pharmaceutical Co., Ltd.
USD 49.50
4519.T
-0.96
-1.91%
GSK plc
USD 19.41
GSK.L
+0.32
1.70%
CSL Limited
USD 157.77
CSL.AX
+0.98
0.62%
Regeneron Pharmaceuticals, Inc.
USD 534.91
REGN
+9.91
1.89%
MERCK Kommanditgesellschaft auf Aktien
USD 132.70
MRK.DE
+3.04
2.35%
Jiangsu Hengrui Medicine Co., Ltd.
USD 7.32
600276.SS
-0.00
-0.06%
Takeda Pharmaceutical Company Limited
USD 30.78
4502.T
+0.14
0.45%
Key Data
| Date | Revenue Per Share | Free Cash Flow Per Share | Dividend Per Share | Debt to Equity Ratio |
|---|
Competitors
AbbVie Inc.
USD 189.99
ABBV
+4.37
2.35%
Novo Nordisk A/S
USD 69.18
NOVO-B.CO
-0.07
-0.11%
Roche Holding AG
USD 347.88
RO.SW
+1.27
0.37%
Novartis AG
USD 123.49
NOVN.SW
+2.27
1.88%
Abbott Laboratories
USD 136.26
ABT
+0.25
0.18%
AstraZeneca PLC
USD 142.95
AZN.L
+3.99
2.87%
Merck & Co., Inc.
USD 81.81
MRK
+2.65
3.35%
Amgen Inc.
USD 290.52
AMGN
+11.31
4.05%
Gilead Sciences, Inc.
USD 111.73
GILD
+0.86
0.78%
Pfizer Inc.
USD 25.04
PFE
+0.80
3.30%
Sanofi
USD 98.07
SAN.PA
+1.17
1.21%
Vertex Pharmaceuticals Incorporated
USD 452.16
VRTX
+6.96
1.56%
Bristol-Myers Squibb Company
USD 47.51
BMY
+1.22
2.64%
Chugai Pharmaceutical Co., Ltd.
USD 49.50
4519.T
-0.96
-1.91%
GSK plc
USD 19.41
GSK.L
+0.32
1.70%
CSL Limited
USD 157.77
CSL.AX
+0.98
0.62%
Regeneron Pharmaceuticals, Inc.
USD 534.91
REGN
+9.91
1.89%
MERCK Kommanditgesellschaft auf Aktien
USD 132.70
MRK.DE
+3.04
2.35%
Jiangsu Hengrui Medicine Co., Ltd.
USD 7.32
600276.SS
-0.00
-0.06%
Takeda Pharmaceutical Company Limited
USD 30.78
4502.T
+0.14
0.45%